Infectious diseases specialists diagnose and treat infections from bacteria, viruses, fungi, and parasites, focusing on fevers, antibiotics, and vaccines.
Send us all your questions or requests, and our expert team will assist you.
Diagnosing typhoid fever poses a significant challenge for clinicians, primarily because its early clinical presentation is indistinguishable from that of other common febrile illnesses endemic to the same regions, such as malaria, dengue fever, and leptospirosis. The classic signs—rose spots, relative bradycardia, and step-ladder fever—are often absent or appear too late to guide initial therapy. Consequently, reliance on clinical symptoms alone leads to misdiagnosis and inappropriate treatment. Definitive diagnosis requires isolating Salmonella Typhi from the patient, which may not always be available in resource-limited settings.
The diagnostic evaluation begins with a thorough history-taking, focusing on the duration of fever (typically prolonged in typhoid), travel history to endemic areas, and potential exposure to contaminated food or water. Physical examination looks for hepatosplenomegaly (enlarged liver and spleen) and abdominal tenderness, but these findings are supportive rather than confirmatory.
The isolation of S. Typhi from the blood remains the gold standard for diagnosis. Blood cultures are most sensitive during the first week of illness when the bacteremia (bacteria in the blood) is highest. About 60 to 80 percent of patients will have a positive blood culture if samples are obtained early, before antibiotics are started.
The procedure involves drawing a significant volume of blood (volume is crucial because the concentration of bacteria can be low, often less than one bacterium per milliliter) and incubating it in a culture medium. Automated blood culture systems have improved detection speed, usually flagging positive results within 24 to 48 hours. Once the bacteria grow, they are identified using biochemical tests or mass spectrometry, and crucially, subjected to antimicrobial susceptibility testing to determine which antibiotics will be effective.
However, the sensitivity of blood cultures decreases significantly in the second and third weeks of illness as the immune system clears bacteria from the blood, which then sequester in tissues. Prior antibiotic use, a common scenario in endemic areas where over-the-counter antibiotics are available, significantly reduces the yield of blood cultures, leading to false-negative results.
Bone marrow culture is considered the most sensitive diagnostic test for typhoid fever, with a sensitivity of over 90 percent. It remains positive even late in the disease course and, importantly, is often unaffected by prior antibiotic treatment up to five days before the test. This is because the bacteria concentrate in the bone marrow and are sequestered intracellularly, protecting them from serum antibiotics.
Despite its diagnostic superiority, bone marrow aspiration is an invasive, painful procedure requiring technical expertise and specialized equipment. Therefore, it is rarely used as a first-line diagnostic tool. It is typically reserved for complex diagnostic dilemmas, patients with fever of unknown origin (FUO), or cases where blood cultures are negative despite a high clinical suspicion of enteric fever.
Stool and urine cultures are generally less helpful for the initial diagnosis of acute typhoid fever. S. Typhi is shed in the stool irregularly and usually only starting from the second or third week of illness. Therefore, a negative stool culture early in the disease does not rule out typhoid.
However, stool cultures are vital for public health surveillance and for monitoring the carrier state. To declare a patient cured or to identify a chronic carrier, serial stool cultures are performed. A chronic carrier is defined as the excretion of S. Typhi in stool for more than 1 year after the acute infection. Urine cultures are generally less sensitive than stool cultures, but may be positive in the later stages.
The Widal test, developed in the late 19th century, measures agglutinating antibodies against the O (somatic) and H (flagellar) antigens of S. Typhi. While it is still widely used in many developing countries due to its low cost and speed, it is fraught with limitations.
The Widal test has poor sensitivity and specificity. It often produces false positives due to cross-reactivity with other non-typhoidal Salmonella species, other bacteria, and even in patients with malaria or dengue. Furthermore, in endemic areas, the “background” level of antibodies in the healthy population is high due to repeated subclinical exposure, making a single test result difficult to interpret. A definitive diagnosis requires demonstrating a fourfold rise in antibody titers between acute and convalescent serum samples taken weeks apart. This requirement offers no help in acute clinical decision-making. Consequently, international guidelines generally discourage reliance on the Widal test.
The limitations of culture (slow) and Widal (inaccurate) have driven the search for rapid diagnostic tests (RDTs). Several lateral flow immunoassays (similar to pregnancy tests) detecting IgM/IgG antibodies or specific antigens are available. While faster, their performance has been variable, and none have yet replaced blood culture as the definitive standard.
Molecular methods like Polymerase Chain Reaction (PCR) and Nucleic Acid Amplification Tests (NAATs) offer high sensitivity and speed. They can detect minute quantities of bacterial DNA in blood or urine. While promising, these technologies require expensive equipment and stable electricity, limiting their widespread deployment in the primary care settings of endemic regions. However, they are increasingly used in reference laboratories and research settings to track strains and resistance markers.
In severe cases, the diagnostic evaluation extends to assessing complications.
Send us all your questions or requests, and our expert team will assist you.
The Widal test measures antibodies, not the bacteria themselves. In areas where typhoid is common, many healthy people have antibodies from past exposure, leading to false-positive results. Also, other infections, such as malaria, can trigger a positive Widal test. Therefore, a positive result does not necessarily mean the patient has active typhoid fever.
No. A bone marrow aspiration is invasive and painful. It is reserved for complex cases in which blood cultures are negative. Still, the doctor strongly suspects typhoid, or when the patient has already taken antibiotics that make blood cultures ineffective. It is a specialized test, not a routine one.
The best time to perform a blood culture is during the first week of fever. This is when the number of circulating bacteria is at its highest. As the disease progresses into the second and third weeks, the bacteria move into tissues, and the chance of a positive blood culture decreases significantly.
While S. Typhi can be found in urine, it is usually only present in the later stages of the disease (after the second week). Furthermore, the presence of bacteria in urine is intermittent. Therefore, urine culture is not a reliable test for diagnosing acute typhoid fever in the early stages.
Leukopenia means a low white blood cell count. In most bacterial infections, the white cell count goes up to fight the bacteria. In typhoid fever, the bacteria suppress the bone marrow, often keeping the white cell count normal or low. This unusual finding can be a helpful clue for doctors suspecting typhoid.
Your Comparison List (you must select at least 2 packages)
